ArticleScientific reports2025
Development and validation of a risk prediction model for post-traumatic stress disorder among Chinese breast cancer survivors.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Post-traumatic stress disorder and social determinants of health among individuals with cancer: association with healthcare utilization and outcomes in the All of Us Research Program.Journal of cancer survivorship : research and practice · 2026Article
- Article
- Cross-lagged analysis of burnout and insomnia in older adult patients with diabetes mellitus complicated by hypertension: a 1-year longitudinal follow-up study.Frontiers in public health · 2025Article
- Prediction and Feature Selection of Mastectomy-Related Post Traumatic Stress Disorder (PTSD) Using Machine Learning Among Breast Cancer Patients in Bangladesh.Cancer informatics · 2025Article
- Cancer as trauma: multidimensional determinants of PTSD across the disease course. A narrative integrative review.Frontiers in psychology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study thoroughly assesses the factors affecting the posttraumatic stress disorder (PTSD) in patients with breast cancers from a multidimensional perspective according to the theory of unpleasant symptoms (TOUS). Additionally, it develops a nomogram prediction model tailored for this group. A cross-section analysis involving seven major hospitals in northern Anhui Province was performed to collect data from 1135 breast cancer survivors. The self-reported Posttraumatic Stress Disorder Checklist-Civilian Version (PCL-C) was applied to evaluate PTSD. Multiple logistic regression analysis was conducted for identifying significant predictive factors of PTSD, and these predictive factors were used to develop and validate a nomogram on an independent validation cohort comprising 481 patients with breast cancers. In the training cohort, 274 patients with breast cancers (24.1%) were identified as having PTSD. The factors independently associated with PTSD included menopause, blood cholesterol levels, fear of cancer progression, psychological distress, depression, social support, and smoking status (all P < 0.05). The area under the curve (AUC) values for training and validation cohorts were 0.889 and 0.770, respectively, indicating strong predictive performance. The calibration plot showed optimal agreement of the observed value with the predicted value, and the decision curve analysis demonstrated strong clinical utility of the nomogram. This study explores the factors affecting PTSD in patients with breast cancers based on the physiological, psychological, and background dimensions of TOUS, and firstly constructs a model for predicting PTSD risk in patients with breast cancers, which demonstrates satisfactory predictive ability and fills a gap in this research field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.